The President of UOKiK has approved a concentration in the pharmaceuticals sector in which Neuca will take over Intra

Neuca heads a capital group whose core area of business is wholesale distribution of pharmaceuticals, as well as running medical clinics and warehousing medicines for other firms. Intra’s main area of business is wholesale of pharmaceutical and veterinary products. It operates mostly in the Mazowiecki Voivodship. 

Following an initial analysis, the Office issued a ruling extending the proceedings to the second phase. A market study revealed a likelihood of limitation of competition on the local market for wholesale of medicine to pharmacies, which was determined to be an area of 110 kilometres from the firm being taken over. This led UOKiK to present an competition concern in October 2016.

-  An analysis of information provided by Neuca in response to the objections presented by UOKiK, as well as the current market climate, led us to issue clearance for the deal. The concentration will not result in significant limitation of competition – Marek Niechciał, President of UOKiK, said.

Additional information for the media:

Press Office, UOKiK
Pl. Powstańców Warszawy 1, 00-950 Warsaw
Phone.: +48 22 827 28 92, +48 22 55 60 314, +48 22 55 60 430
E-mail: [SCODE]Yml1cm9wcmFzb3dlQHVva2lrLmdvdi5wbA==[ECODE]

Twitter: @UOKiKgovPL